[go: up one dir, main page]

WO1996026710A1 - Cosmetic and/or pharmaceutical preparations - Google Patents

Cosmetic and/or pharmaceutical preparations Download PDF

Info

Publication number
WO1996026710A1
WO1996026710A1 PCT/EP1996/000740 EP9600740W WO9626710A1 WO 1996026710 A1 WO1996026710 A1 WO 1996026710A1 EP 9600740 W EP9600740 W EP 9600740W WO 9626710 A1 WO9626710 A1 WO 9626710A1
Authority
WO
WIPO (PCT)
Prior art keywords
dimer diol
cosmetic
technical
mixtures
trimer triol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1996/000740
Other languages
German (de)
French (fr)
Inventor
Achim Ansmann
Rolf Kawa
Annette Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of WO1996026710A1 publication Critical patent/WO1996026710A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the invention relates to cosmetic and / or pharmaceutical preparations containing selected polyols and the use of the polyols as oil bodies.
  • oil-soluble bases are needed, the task of which is to transport polar ingredients, such as, for example, active ingredients or moisture, through the lipid barrier of the skin.
  • polar ingredients such as, for example, active ingredients or moisture
  • a variety of natural and synthetic oils are suitable for this purpose, for example almond or avocado oil or ester oils based on short-chain triglycerides.
  • the oil components in the agents mentioned also have a nourishing effect which is directly related to the skin oiling. Products are desired by the consumer which impart a non-sticky feeling of skin smoothness and suppleness that occurs as quickly as possible and lasts longer.
  • cosmetic oil bodies can be divided into low-spreading (below 300 mm 2 / 10min), medium-spreading (approx. 300 to 1000 mm 2 / 10min) and high-spreading oils (above 1000 mm 2 / 10min).
  • Emulsions for the formulation of extensive care and Massageöl- are oil bodies with high greasiness, ie with a low Speit capacity of less than 100 mm 2/10 minutes erforder ⁇ Lich. These include vegetable oils, (33 2 mm / 10 min), such as peanut oil (62 mm 2/10 min) or castor oil.
  • vegetable oils (33 2 mm / 10 min)
  • peanut oil 62 mm 2/10 min
  • castor oil castor oil.
  • concentrations above 15% by weight for example, no longer lead to the formation of an emulsion.
  • a further disadvantage is the susceptibility to oxidation of the oil bodies mentioned at the outset and the fact that they are practically insoluble in polar media such as, for example, ethanol.
  • the complex object of the present invention was therefore to provide cosmetic and / or pharmaceutical preparations with an oil body content that have a low Zeidler spreading value of ⁇ 100 mm / 10 min, can be easily in W / Have O-emulsions incorporated, little susceptible to oxidation and moreover are still satisfactorily soluble in polar media such as ethanol.
  • the invention relates to cosmetic and pharmaceutical preparations containing technical dimer diol / trimer triol mixtures with an average of 24 to 66, preferably 36 to 54 carbon atoms.
  • Dimer diol / trimer triols are technical mixtures which are obtained by oligomerizing unsaturated fatty acids having 12 to 22, preferably 16 to 18 carbon atoms or their methyl esters and subsequent high-pressure hydrogenation.
  • the oligomerization of unsaturated fatty acids is a known electrocyclic reaction, about which in review articles, for example by A. Behr in Fat Sei. Technol. 93, 340 (1991), G.Spiteller in Fat Sei.Technol. .94 * 41 (1992) or P.Daute et al. in Fat Sei.Technol. J95_, 91 (1993) is reported.
  • oligomerization In oligomerization, on average two to three fatty acids come together and form dimers or trimers, which predominantly have cycloaliphatic structures. In addition to the fraction of the dimers and trimers, a so-called monomer fraction is obtained in which there are unreacted starting materials and branched monomers which have arisen in the course of the reaction by isomerization. There is of course also a fraction of higher oligomers, which, however, is generally not of major importance.
  • the oligomerization can be carried out thermally or in the presence of noble metal catalysts.
  • the reaction is preferably carried out in the presence of clays such as montomorillonite [cf. Greases, soaps, paints. 72, 667 (1970)].
  • the regulation of the content of dimers and trimers and the extent of the monomer fraction can be controlled by the reaction conditions.
  • Typical examples are palmoleic acid, oleic acid, elaidic acid, petroselinyl acid, linoleic acid, linolenic acid, conjugated fatty acid, elaeostearic acid, ricinoleic acid, gadoleic acid, erucic acid and their technical mixtures with saturated fatty acids.
  • Typical examples of suitable technical mixtures are uncured split fatty acids from natural triglyc ride with iodine numbers in the range from 40 to 140, such as palm fatty acid, tallow fatty acid, rapeseed oil fatty acid, sunflower fatty acid and the like. Split fatty acids with a high oleic acid content are preferred.
  • esters In addition to the fatty acids, their esters, preferably methyl esters, can also be dimerized. It is also possible to oligomerize the acid and convert it to the methyl ester before the hydrogenation.
  • the acid or ester group is hydrogenated to the alcohol group in a manner known per se in the presence of heterogeneous cupfer / chromium or cupfer / zinc catalysts at temperatures in the range from 200 to 300 ° C. and pressures of about 250 to 350 bar .
  • Dimer diol / trimer diol mixtures which are particularly preferred for the purposes of the invention, are obtained by oligomerizing technical oleic acid and subsequent high-pressure hydrogenation and have a dimer diol content of 33 to 99% by weight and a trimer triol content of 1 to 67% by weight. % on.
  • the monomer content can be 1 to 15% by weight and, if necessary, reduced by distillation.
  • Cosmetic or pharmaceutical preparations are primarily to be understood as skin care products which can contain the technical dimer diol / trimer triol mixtures in amounts of 1 to 35 and preferably 5 to 25% by weight, based on the composition.
  • the agents according to the invention such as creams and lotions, can contain additional oil bodies, emulsifiers, fats and waxes, stabilizers and superfatting agents, thickeners, biogenic agents, film formers, preservatives, colorants and fragrances exhibit.
  • Suitable emulsifiers are both known W / O and 0 / W emulsifiers, such as, for example, hardened and ethoxylated castor oil, polyglycerol fatty acid esters or polyglycerol poly ricinoleates or hydroxystearates, and also fatty alcohol sulfates, soaps, fatty alcohol ethoxylates, alkyl oligoglucosides and the like.
  • Typical examples of fats are glycerides, waxes which may be used include beeswax, paraffin wax or microwaxes, if appropriate in combination with hydrophilic waxes, for example cetylstearyl alcohol.
  • Metal salts of fatty acids such as magnesium, aluminum and / or zinc stearate can be used as stabilizers.
  • Substances such as, for example, polyethoxylated lanolin derivatives, lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Suitable thickeners are, for example, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinyl pyrrolidone.
  • Biogenic active substances are understood to mean, for example, plant extracts and vitamin complexes.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinyl pyrrolidone, vinyl pyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid.
  • Suitable pearlizing agents are, for example, glycol distearic acid esters such as ethylene glycol distearate, but also fatty acid monoglycol esters.
  • the dyes which can be used are the substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” of the Dye Controls of the German Research Foundation, published by Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40% by weight and the non-aqueous proportion (“active substance content”) 20 to 80, preferably 30 to 70% by weight, based on the composition.
  • the preparation of the agents can be carried out in a manner known per se, i.e. for example by hot, cold, hot-hot / cold or PIT emulsification. This is a purely mechanical process, there is no chemical reaction.
  • the technical dimer diol / trimer triol mixtures are notable for their high fatness and low spreading capacity. They can be easily incorporated into emulsions and are surprisingly readily soluble in polar media. Another object of the invention therefore relates to their use as oil bodies or superfatting agents for the production of cosmetic and / or pharmaceutical preparations in which they are present in concentrations of 1 to 35, preferably 5 to 25% by weight on the means - may be included.
  • Lameform ( R ) TGI polyglyceryl-3-diisostearate.
  • Emulsions I to III are according to the invention, emulsion IV is used for comparison. While highly viscous creams with a rich care effect were obtained in the first three cases, in the case of the comparative example it was not possible to produce a stable emulsion.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)

Abstract

The invention concerns novel cosmetic and pharmaceutical preparations containing technical dimeric diol/trimeric triol mixtures with on average 24-66 carbon atoms. The polyols can be used as oils and are characterised by a low spreading capability.

Description

Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations

Gebiet der ErfindungField of the Invention

Die Erfindung betrifft kosmetische und/oder pharmazeutische Zubereitungen mit einem Gehalt an ausgewählten Polyolen sowie die Verwendung der Polyole als ölkörper.The invention relates to cosmetic and / or pharmaceutical preparations containing selected polyols and the use of the polyols as oil bodies.

Stand d*yr 1V»r-hτι<VStand d * yr 1V »r-hτι <V

Zur Herstellung kosmetischer bzw. pharmazeutischer Mittel, beispielsweise Cremes, Lotionen oder Salben, werden öllös- liche Grundlagen benötigt, deren Aufgabe es ist, polare In- haltssstoffe, wie beispielsweise Wirkstoffe oder Feuchtig¬ keit, durch die Lipidbarriere der Haut zu transportieren. Für diesen Zweck eignen sich eine Vielzahl von natürlichen und synthetischen ölen, beispielsweise Mandel- oder Avocadoöl oder Esteröle auf Basis von kurzkettigen Triglyceriden. Den ölkomponenten in den angesprochenen Mitteln kommt gleichzei¬ tig auch eine pflegende Wirkung zu, die in unmittelbarem Zu¬ sammenhang mit der Hautfettung steht. Vom Konsumenten ge¬ wünscht sind Produkte, die ein nichtklebriges, möglichst rasch eintretendes und längeranhaltendes Gefühl der Hautglät¬ te- und -geschmeidigkeit vermitteln. Das subjektive Empfinden auf der Haut kann mit dem physiko- chemisehen Parameter der Spreitung der ölkörper auf der Haut korreliert und objektiviert werden, wie dies von U.Zeidler in Fette, Seifen, Anstrichmitt. 82, 403 (1985) dargestellt wor¬ den ist. Demnach lassen sich kosmetische ölkörper in niedrig¬ spreitende (unter 300 mm2/10min), mittelspreitende (ca. 300 bis 1000 mm2/10min) und hochspreitende öle (oberhalb 1000 mm2/10min) einteilen.For the production of cosmetic or pharmaceutical agents, for example creams, lotions or ointments, oil-soluble bases are needed, the task of which is to transport polar ingredients, such as, for example, active ingredients or moisture, through the lipid barrier of the skin. A variety of natural and synthetic oils are suitable for this purpose, for example almond or avocado oil or ester oils based on short-chain triglycerides. At the same time, the oil components in the agents mentioned also have a nourishing effect which is directly related to the skin oiling. Products are desired by the consumer which impart a non-sticky feeling of skin smoothness and suppleness that occurs as quickly as possible and lasts longer. The subjective sensation on the skin can be correlated and objectified with the physico-chemical parameter of the spreading of the oil bodies on the skin, as described by U. Zeidler in fats, soaps, paints. 82, 403 (1985). Accordingly, cosmetic oil bodies can be divided into low-spreading (below 300 mm 2 / 10min), medium-spreading (approx. 300 to 1000 mm 2 / 10min) and high-spreading oils (above 1000 mm 2 / 10min).

Für die Formulierung von reichhaltigen Pflege- und Massageöl- emulsionen sind ölkörper mit hoher Fettigkeit, d.h. mit einem niedrigen Speitvermögen von kleiner 100 mm2/10 min erforder¬ lich. Hierzu zählen pflanzliche öle, wie z.B. Erdnußöl (62 mm2/10 min) oder Ricinusöl (33 mm2/10 min). Stoffe dieser Art sind jedoch aufgrund ihres hohen Molekulargewichtes, insbe¬ sondere in W/O-Emulsionen nur schwer emulgierbar [vgl. Ans- mann et al. in Seifen-Öle-Fette-Wachse 117. 158 (1991)]. Bei Verwendung von Ricinusöl kommt es in Konzentrationen oberhalb von 15 Gew.-% beispielsweise überhaupt nicht mehr zur Bildung einer Emulsion. Von Nachteil ist zudem die Oxidationsanfäl- ligkeit der eingangs genannten ölkörper sowie der Umstand, daß sie in polaren Medien wie beispielsweise Ethanol prak¬ tisch unlöslich sind.Emulsions for the formulation of extensive care and Massageöl- are oil bodies with high greasiness, ie with a low Speit capacity of less than 100 mm 2/10 minutes erforder¬ Lich. These include vegetable oils, (33 2 mm / 10 min), such as peanut oil (62 mm 2/10 min) or castor oil. However, substances of this type are difficult to emulsify due to their high molecular weight, particularly in W / O emulsions [cf. Ansmann et al. in Soap-Oil-Fat-Waxes 117, 158 (1991)]. When using castor oil, concentrations above 15% by weight, for example, no longer lead to the formation of an emulsion. A further disadvantage is the susceptibility to oxidation of the oil bodies mentioned at the outset and the fact that they are practically insoluble in polar media such as, for example, ethanol.

Die komplexe Aufgabe der vorliegenden Erfindung hat somit darin bestanden, kosmetische und/oder pharmazeutische Zube¬ reitungen mit einem Gehalt an ölkörpern zur Verfügung zu stellen, die über einen niedrigen Spreitwert nach Zeidler von < 100 mm /10 min verfügen, sich problemlos in W/O-Emulsionen einarbeiten lassen, wenig oxidationsanfällig und zudem noch noch in polaren Medien wie beispielsweise Ethanol zufrieden¬ stellend löslich sind.The complex object of the present invention was therefore to provide cosmetic and / or pharmaceutical preparations with an oil body content that have a low Zeidler spreading value of <100 mm / 10 min, can be easily in W / Have O-emulsions incorporated, little susceptible to oxidation and moreover are still satisfactorily soluble in polar media such as ethanol.

Beschreibunσ der ErfindungDescription of the invention

Gegenstand der Erfindung sind kosmetische und pharmazeutische Zubereitungen, enthaltend technische Dimerdiol/Trimertriol- Gemische mit durchschnittlich 24 bis 66, vorzugsweise 36 bis 54 Kohlenstoffatomen.The invention relates to cosmetic and pharmaceutical preparations containing technical dimer diol / trimer triol mixtures with an average of 24 to 66, preferably 36 to 54 carbon atoms.

Überraschenderweise wurde gefunden, daß technische Gemische von Dimerdiolen und Trimertriolen hochfettend und niedrig¬ spreitend sind (Spreitwert ca. 50 mm /10 min), sich problem¬ los in kosmetische Emulsionen einarbeiten lassen und gegen¬ über Autoxidation sehr beständig sind. Zudem schließt die Erfindung die Erkenntnis ein, daß die Polyole eine ausge¬ zeichnete Alkohol/Wasser-Löslichkeit aufweisen. So können z.B. zu 100 g einer 5 Gew.-%igen ethanolischen Lösung eines technischen D-Lmerdiol/Trimertriol-Gemisches 25 g Wasser zu¬ gegeben werden, ohne daß sich die Lösung trübt bzw. Phasen¬ trennung eintritt.Surprisingly, it was found that technical mixtures of dimer diols and trimer triols are high-fat and low-spreading (spreading value approx. 50 mm / 10 min), can be incorporated into cosmetic emulsions without problems and are very resistant to autoxidation. The invention also includes the knowledge that the polyols have excellent alcohol / water solubility. For example, 25 g of water are added to 100 g of a 5% strength by weight ethanolic solution of a technical D-lmerdiol / trimer triol mixture without the solution becoming cloudy or phase separation occurring.

Dimerdiol/Trimertriol-GemischeDimer diol / trimer triol mixtures

Unter Dimerdiol/Trimertriolen sind technische Gemische zu verstehen, die durch Oligomerisierung von ungesättigten Fettsäuren mit 12 bis 22, vorzugsweise 16 bis 18 Kohlen¬ stoffatomen oder deren Methylester und nachfolgende Hoch¬ druckhydrierung erhalten werden. Die Oligomerisierung von ungesättigten Fettsäuren stellt eine bekannte elektrocyclische Reaktion dar, über die in Über¬ sichtsartikeln beispielsweise von A.Behr in Fat Sei. Technol. 93. 340 (1991), G.Spiteller in Fat Sei.Technol. .94* 41 (1992) oder P.Daute et al. in Fat Sei.Technol. J95_, 91 (1993) berich¬ tet wird. Bei der Oligomerisierung treten durchschnittlich zwei bis drei Fettsäuren zusammen und bilden Dimere bzw. Tri- mere, die überwiegend cycloaliphatische Strukturen aufweisen. Neben der Fraktion der Dimeren und Trimeren wird eine soge¬ nannte Monomerfraktion erhalten, in der sich nicht umgesetzte Ausgangsstoffe und verzweigte Monomere befinden, die im Ver¬ lauf der Reaktion durch Isomerisierung entstanden sind. Dane¬ ben gibt es selbstverständlich auch eine Fraktion höherer Oligomeren, die jedoch in der Regel nicht von größerer Bedeu¬ tung ist. Die Oligomerisierung kann thermisch oder in Gegen¬ wart von Edelmetallkatalysatoren durchgeführt werden. Vor¬ zugsweise erfolgt die Reaktion in Gegenwart von Tonerden wie beispielsweise Montomorillonit [vgl. Fette, Seifen, Anstrich- mitt. 72,, 667 (1970)]. Die Regelung des Gehaltes an Dimeren und Trimeren bzw. der Umfang der Monomerfraktion kann durch die Reaktionsbedingungen gesteuert werden.Dimer diol / trimer triols are technical mixtures which are obtained by oligomerizing unsaturated fatty acids having 12 to 22, preferably 16 to 18 carbon atoms or their methyl esters and subsequent high-pressure hydrogenation. The oligomerization of unsaturated fatty acids is a known electrocyclic reaction, about which in review articles, for example by A. Behr in Fat Sei. Technol. 93, 340 (1991), G.Spiteller in Fat Sei.Technol. .94 * 41 (1992) or P.Daute et al. in Fat Sei.Technol. J95_, 91 (1993) is reported. In oligomerization, on average two to three fatty acids come together and form dimers or trimers, which predominantly have cycloaliphatic structures. In addition to the fraction of the dimers and trimers, a so-called monomer fraction is obtained in which there are unreacted starting materials and branched monomers which have arisen in the course of the reaction by isomerization. There is of course also a fraction of higher oligomers, which, however, is generally not of major importance. The oligomerization can be carried out thermally or in the presence of noble metal catalysts. The reaction is preferably carried out in the presence of clays such as montomorillonite [cf. Greases, soaps, paints. 72, 667 (1970)]. The regulation of the content of dimers and trimers and the extent of the monomer fraction can be controlled by the reaction conditions.

Als Ausgangsstoffe für die Oligomerisierung kommen wie schon ausgeführt technische ungesättigte Fettsäuren mit 12 bis 22 und vorzugsweise 16 bis 18 Kohlenstoffatomen in Betracht. Typische Beispiele sind Palmoleinsäure, lsäure, Elaidyl- säure, Petroselinylsäure, Linolsäure, Linolensäure, Konjuen- fettsäure, ElaeoStearinsäure, Ricinolsäure, Gadoleinsäure, Erucasäure sowie deren technische Gemische mit gesättigten Fettsäuren. Typische Beispiele für geeignete technische Ge¬ mische sind ungehärtete Spaltfettsäuren natürlicher Triglyce- ride mit Iodzahlen im Bereich von 40 bis 140, wie etwa Palm¬ fettsäure, Taigfettsäure, Rübölfettsäurem, Sonnenblumenfett¬ säure und dergleichen. Bevorzugt sind Spaltfettsäuren mit einem hohen Gehalt an ölsäure.As already mentioned, technical unsaturated fatty acids with 12 to 22 and preferably 16 to 18 carbon atoms are suitable as starting materials for the oligomerization. Typical examples are palmoleic acid, oleic acid, elaidic acid, petroselinyl acid, linoleic acid, linolenic acid, conjugated fatty acid, elaeostearic acid, ricinoleic acid, gadoleic acid, erucic acid and their technical mixtures with saturated fatty acids. Typical examples of suitable technical mixtures are uncured split fatty acids from natural triglyc ride with iodine numbers in the range from 40 to 140, such as palm fatty acid, tallow fatty acid, rapeseed oil fatty acid, sunflower fatty acid and the like. Split fatty acids with a high oleic acid content are preferred.

Neben den Fettsäuren können auch deren Ester, vorzugsweise Methylester dimerisiert werden. Es ist gleichfalls möglich, die Säure zu oligomerisieren und vor der Hydrierung in die Methylester zu überführen. Die Hydrierung der Säure- bzw. Ester- zur Alkoholgruppe gelingt in an sich bekannter Weise in Gegenwart heterogener Cupfer/Chrom- oder Cupfer/Zink-Ka¬ talysatoren bei Temperaturen im Bereich von 200 bis 300°C und Drücken von etwa 250 bis 350 bar.In addition to the fatty acids, their esters, preferably methyl esters, can also be dimerized. It is also possible to oligomerize the acid and convert it to the methyl ester before the hydrogenation. The acid or ester group is hydrogenated to the alcohol group in a manner known per se in the presence of heterogeneous cupfer / chromium or cupfer / zinc catalysts at temperatures in the range from 200 to 300 ° C. and pressures of about 250 to 350 bar .

Dimerdiol/Trimerdiol-Gemische, die im Sinne der Erfindung besonders bevorzugt sind, werden durch Oligomerisierung von technischer ölsäure und nachfolgende Hochdruckhydrierung er¬ halten werden und weisen einen Dimerdiolgehalt von 33 bis 99 Gew.-% sowie einen Trimertriolgehalt von 1 bis 67 Gew.-% auf. Der Gehalt an Monomeren kann 1 bis 15 Gew.-% betragen und falls erforderlich durch Destillation erniedrigt werden.Dimer diol / trimer diol mixtures, which are particularly preferred for the purposes of the invention, are obtained by oligomerizing technical oleic acid and subsequent high-pressure hydrogenation and have a dimer diol content of 33 to 99% by weight and a trimer triol content of 1 to 67% by weight. % on. The monomer content can be 1 to 15% by weight and, if necessary, reduced by distillation.

Kosmetische- und/oder pharmazeutische ZubereitungenCosmetic and / or pharmaceutical preparations

Unter kosmetischen bzw. pharmazeutischen Zubereitungen sind in erster Linie Hautpflegemittel zu verstehen, die die tech¬ nischen Dimerdiol/Trimertriol-Gemische in Mengen von 1 bis 35 und vorzugsweise 5 bis 25 Gew.-% - bezogen auf die Mittel - enthalten können. Weiterhin können die erfindungsgemäßen Mittel, wie beispiels¬ weise Cremes und Lotionen einen Gehalt an zusätzlichen öl- körpern, Emulgatoren, Fetten und Wachsen, Stabilisatoren so¬ wie Überfettungsmitteln, Verdickungsmitteln, biogenen Wirk¬ stoffen, Filmbildnern, Konservierungsmitteln, Färb- und Duft¬ stoffen aufweisen.Cosmetic or pharmaceutical preparations are primarily to be understood as skin care products which can contain the technical dimer diol / trimer triol mixtures in amounts of 1 to 35 and preferably 5 to 25% by weight, based on the composition. Furthermore, the agents according to the invention, such as creams and lotions, can contain additional oil bodies, emulsifiers, fats and waxes, stabilizers and superfatting agents, thickeners, biogenic agents, film formers, preservatives, colorants and fragrances exhibit.

Als weitere lkörper kommen beispielsweise Guerbetalkohole auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 Kohlenstoffatomen, Ester von linearen C6-C20-Fettsäuren mit linearen Cg- C20~Fettalk°h°len.' Ester von verzweigten C - Ci3-Carbonsäuren mit linearen

Figure imgf000008_0001
Ester von linearen Cιo-C18~Fβtt8*urθn ∞^ verzweigten Alkoholen, insbesondere 2-Ethylhexanol, Ester von linearen und/oder verzweigten Fettsäuren mit zweiwertigen Alkoholen und/oder Guer-betalkoholen, Triglyceride auf Basis C -Cιo~Fe<ttsäuren, pflanzliche öle, verzweigte primäre Alkohole, substituierte Cyclohexane, Guerbetcarbonate und/oder Dialkylether in Be¬ tracht.As a further lkörper example, Guerbet alcohols based on fatty alcohols having 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C6-C20 fatty acids with linear Cg-C20 ~ lk Fetta ° h ° l s. ' Esters of branched C - Ci3 carboxylic acids with linear
Figure imgf000008_0001
Esters of linear -C 18 ~ Fβtt8 * urθn ∞ ^ branched alcohols, especially 2-ethylhexanol, esters of linear and / or branched fatty acids with dihydric alcohols and / or Guerbet alcohols, triglycerides based on C -Cιo ~ Fe <t tsÄure , vegetable oils, branched primary alcohols, substituted cyclohexanes, Guerbet carbonates and / or dialkyl ethers.

Als Emulgatoren kommen sowohl bekannte W/O- als auch 0/W- Emulgatoren wie beispielsweise gehärtetes und ethoxyliertes Ricinusöl, Polyglycerinfettsäureester oder Polyglycerinpoly- ricinoleate bzw. -hydroxystearate sowie Fettalkoholsulfate, Seifen, Fettalkoholethoxylate, Alkyloligoglucoside und der¬ gleichen in Frage.Suitable emulsifiers are both known W / O and 0 / W emulsifiers, such as, for example, hardened and ethoxylated castor oil, polyglycerol fatty acid esters or polyglycerol poly ricinoleates or hydroxystearates, and also fatty alcohol sulfates, soaps, fatty alcohol ethoxylates, alkyl oligoglucosides and the like.

Typische Beispiele für Fette sind Glyceride, als Wachse kom¬ men u.a. Bienenwachs, Paraffinwachs oder Mikrowachse gegebe¬ nenfalls in Kombination mit hydrophilen Wachsen, z.B. Cetyl- stearylalkohol in Frage. Als Stabilisatoren können Metallsalze von Fettsäuren wie z.B. Magnesium-, Aluminium und/oder Zinkstearat eingesetzt werden.Typical examples of fats are glycerides, waxes which may be used include beeswax, paraffin wax or microwaxes, if appropriate in combination with hydrophilic waxes, for example cetylstearyl alcohol. Metal salts of fatty acids such as magnesium, aluminum and / or zinc stearate can be used as stabilizers.

Als Überfettungsmittel können Substanzen wie beispielsweise polyethoxylierte Lanolinderivate, Lecithinderivate, Polyol- fettsäureester, Monoglyceride und Fettsäurealkanolamide ver¬ wendet werden, wobei die letzteren gleichzeitig als Schaum¬ stabilisatoren dienen.Substances such as, for example, polyethoxylated lanolin derivatives, lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.

Geeignete Verdickungsmittel sind beispielsweise Polysaccha- ride, insbesondere Xanthan-Gum, Guar-Guar, Agar-Agar, Algi- nate und Tylosen, Carboxymethylcellulose und Hydroxyethyl- cellulose, ferner höhermolekulare Polyethylenglycolmono- und -diester von Fettsäuren, Polyacrylate, Polyvinylalkohol und Polyvinylpyrrolidon.Suitable thickeners are, for example, polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, polyvinyl alcohol and polyvinyl pyrrolidone.

Unter biogenen Wirkstoffen sind beispielsweise Pflanzenex¬ trakte und Vitaminkomplexe zu verstehen.Biogenic active substances are understood to mean, for example, plant extracts and vitamin complexes.

Gebräuchliche Filmbildner sind beispielsweise Chitosan, mi¬ krokristallines Chitosan, quatemiertes Chitosan, Polyvinyl¬ pyrrolidon, Vinylpyrrolidon-Vinyl-acetat-Copolymerisate, Po¬ lymere der Acrylsäurereihe, quaternäre Cellulose-Derivate, Kollagen, Hyaluronsäure bzw. deren Salze und ähnliche Verbin¬ dungen.Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinyl pyrrolidone, vinyl pyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.

Als Konservierungsmittel eignen sich beispielsweise Phenoxy- ethanol, Formaldehydlösung, Parabene, Pentandiol oder Sorbin¬ säure. Als Perlglanzmittel kommen beispielsweise Glycoldistearin- säureester wie Ethylenglycoldistearat, aber auch Fettsäure- monoglycolester in Betracht.Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid. Suitable pearlizing agents are, for example, glycol distearic acid esters such as ethylene glycol distearate, but also fatty acid monoglycol esters.

Als Farbstoffe können die für kosmetische Zwecke geeigneten und zugelassenen Substanzen verwendet werden, wie sie bei¬ spielsweise in der Publikation "Kosmetische Färbemittel" der Farbstoffkσmmissiσn der Deutschen Forschungsgemeinschaft, veröffentlicht im Verlag Chemie, Weinheim, 1984, S.81-106 zusammengestellt sind. Diese Farbstoffe werden üblicherweise in Konzentrationen von 0,001 bis 0,1 Gew.-%, bezogen auf die gesamte Mischung, eingesetzt.The dyes which can be used are the substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes" of the Dye Controls of the German Research Foundation, published by Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.

Der Gesamtanteil der Hilfs- und Zusatzstoffe kann 1 bis 50, vorzugsweise 5 bis 40 Gew.-% und der nicht wäßrige Anteil ("Aktivsubstanzgehalt") 20 bis 80, vorzugsweise 30 bis 70 Gew.-% - bezogen auf die Mittel - betragen. Die Herstellung der Mittel kann in an sich bekannter Weise, d.h. beispiels¬ weise durch Heiß-, Kalt-, Heiß-Heiß/Kalt- bzw. PIT-Emulgie- rung erfolgen. Hierbei handelt es sich um ein rein mechani¬ sches Verfahren, eine chemische Reaktion findet nicht statt.The total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40% by weight and the non-aqueous proportion (“active substance content”) 20 to 80, preferably 30 to 70% by weight, based on the composition. The preparation of the agents can be carried out in a manner known per se, i.e. for example by hot, cold, hot-hot / cold or PIT emulsification. This is a purely mechanical process, there is no chemical reaction.

Gewerbliche AnwendbarkeitIndustrial applicability

Die technischen Dimerdiol/Trimertriol-Gemische zeichnen sich durch eine hohe Fettigkeit und ein niedriges Spreitvermögen aus. Sie lassen sich problemlos in Emulsionen einarbeiten und sind überraschend gut in polaren Medien löslich. Ein weiterer Gegenstand der Erfindung betrifft daher ihre Verwendung als ölkörper oder Überfettungsmittel für die Her¬ stellung von kosmetischen und/oder pharmazeutischen Zuberei¬ tungen, in denen sie in Konzentrationen von 1 bis 35, vor¬ zugsweise 5 bis 25 Gew.-% - bezogen auf die Mittel - enthal¬ ten sein können.The technical dimer diol / trimer triol mixtures are notable for their high fatness and low spreading capacity. They can be easily incorporated into emulsions and are surprisingly readily soluble in polar media. Another object of the invention therefore relates to their use as oil bodies or superfatting agents for the production of cosmetic and / or pharmaceutical preparations in which they are present in concentrations of 1 to 35, preferably 5 to 25% by weight on the means - may be included.

Die folgenden Beispiele sollen den Gegenstand der Erfindung näher erläutern, ohne ihn darauf einzuschränken. The following examples are intended to explain the subject matter of the invention in more detail without restricting it.

BeispieleExamples

I. rHπ-γ-ag-y z e ölkörperI. rHπ-γ-ag-y z e oil body

Die Kenndaten und Zusammensetzung der als ölkörper eingesetz¬ ten technischen Dxmer-/Trxmerdiole sind in Tabelle 1 zusam¬ mengefaßt:The characteristic data and composition of the technical dihydro / diols used as oil bodies are summarized in Table 1:

Tabelle 1 Kennzahlen technischer DimerdioleTable 1 Key figures for technical dimer diols

Sovermol Sovermol Sovermol 650 NS POL 900 POL 930Sovermol Sovermol Sovermol 650 NS POL 900 POL 930

Säurezahl < 1 < 1 < 1 Hydroxylzahl 180-200 180-210 190-210 Viskosität (mPa*s) 5000 3000 6000Acid number <1 <1 <1 hydroxyl number 180-200 180-210 190-210 Viscosity (mPa * s) 5000 3000 6000

Monomergeha1t (Gew.-%) 13 < 2 4 Dimergeha1t (Gew.-%) 68 > 96 45 Trimergehalt (Gew.-%) 19 < 2 51Monomer content (% by weight) 13 <2 4 Dimer content (% by weight) 68> 96 45 Trimer content (% by weight) 19 <2 51

Die drei oben genannten technischen Dimerdiol/Trimertriol- Gemische stellen HändeIsprodukte der Henkel KGaA, Düsseldorf/ FRG dar. Folgende Emulsionen wurden unter ihrer Mitverwendung hergestellt (vgl. Tabelle 2, Prozentangaben als Gew.-%): Tabelle 2 Erfindungsgemäße Emulsionen und VergleichsbeispielThe three technical dimer diol / trimer triol mixtures mentioned above are hand-made products from Henkel KGaA, Düsseldorf / FRG. The following emulsions were produced with their use (see Table 2, percentages as% by weight): Table 2 Emulsions according to the invention and comparative example

Komponente τ II III rvComponent τ II III rv

% % % %%%%%

Lanette(R) 0 1 1 1 1Lanette ( R ) 0 1 1 1 1

Dehymuls(R) FCE 2 2 2 2Dehymuls ( R ) FCE 2 2 2 2

Lameform(R) TGI 4 4 4 4Lameform ( R ) TGI 4 4 4 4

Mikrowachs 7 7 7 7Micro wax 7 7 7 7

Sovermol(R) 650 NS 21 - - -Sovermol ( R ) 650 NS 21 - - -

Sovermol(R) POL 900 - 21 - -Sovermol ( R ) POL 900 - 21 - -

Sovermol(R) POL 930 - - 21 -Sovermol ( R ) POL 930 - - 21 -

Ricinusöl - - - 21Castor oil - - - 21

Glycerin 5 5 5 5Glycerin 5 5 5 5

Magnesiumsulfat 1 1 1 1Magnesium sulfate 1 1 1 1

Wasser ad 1( )0 Gew.- -%Water ad 1 () 0% by weight -%

Legende: Lanette(R) 0 ■ Cetearyl Alcohol; Dehymuls(R) FCE * Dicocoyl Pentaerythrit Distearyl CiträteLegend: Lanette ( R ) 0 ■ Cetearyl Alcohol; Dehymuls ( R ) FCE * dicocoyl pentaerythritol distearyl citrate

Lameform(R) TGI = Polyglyceryl-3-Diisostearate.Lameform ( R ) TGI = polyglyceryl-3-diisostearate.

Die Emulsionen I bis III sind erfindungsgemäß, Emulsion IV dient zum Vergleich. Während in den ersten drei Fällen hoch¬ viskose Cremes mit reichhaltigem Pflegeeffekt erhalten wur¬ den, gelang im Fall des Vergleichsbeispiels keine Herstellung einer stabilen Emulsion. Emulsions I to III are according to the invention, emulsion IV is used for comparison. While highly viscous creams with a rich care effect were obtained in the first three cases, in the case of the comparative example it was not possible to produce a stable emulsion.

Claims

- ,2 -Patentansprüche -, 2 -patent claims 1. Kosmetische und pharmazeutische Zubereitungen, enthal¬ tend technische Dimerdiol/Trimertriol-Gemische mit durchschnittlich 24 bis 66 Kohlenstoffatomen.1. Cosmetic and pharmaceutical preparations containing technical dimer diol / trimer triol mixtures with an average of 24 to 66 carbon atoms. 2. Zubereitungen nach Anspruch 1, dadurch gekennzeichnet, daß sie technischen Dimerdiol/Trimertriol-Gemische ent¬ halten, die durch Oligomerisierung von ungesättigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen oder deren Methylester und nachfolgende Hochdruckhydrierung erhal¬ ten werden.2. Preparations according to claim 1, characterized in that they contain technical dimer diol / trimer triol mixtures which are obtained by oligomerizing unsaturated fatty acids having 12 to 22 carbon atoms or their methyl esters and subsequent high-pressure hydrogenation. 3. Zubereitungen nach den Ansprüchen 1 und 2, dadurch ge¬ kennzeichnet, daß sie technische Dimerdiol/Trimertriol- Gemische enthalten, die durch Oligomerisierung von tech¬ nischer ölsäure und nachfolgende Hochdruckhydrierung erhalten werden.3. Preparations according to claims 1 and 2, characterized ge indicates that they contain technical dimer diol / trimer triol mixtures which are obtained by oligomerization of technical oleic acid and subsequent high pressure hydrogenation. 4. Zubereitungen nach den Ansprüchen 1 bis 3, dadurch ge¬ kennzeichnet, daß sie technische Dimerdiol/Trimertriol- Gemische enthalten, die einen Dimerdiolgehalt von 33 bis 99 Gew.-% und einen Trimertriolgehalt von 1 bis 67 Gew.-% aufweisen.4. Preparations according to claims 1 to 3, characterized ge indicates that they contain technical dimer diol / trimer triol mixtures which have a dimer diol content of 33 to 99 wt .-% and a trimer triol content of 1 to 67 wt .-%. 5. Zubereitungen nach den Ansprüchen 1 bis 4, dadurch ge¬ kennzeichnet, daß sie die technischen Dimerdiol/Trimer¬ triol-Gemische in Mengen von 1 bis 35 Gew.-% - bezogen auf die Mittel - enthalten. 5. Preparations according to claims 1 to 4, characterized ge indicates that they contain the technical dimer diol / trimer triol mixtures in amounts of 1 to 35 wt .-% - based on the composition. 6. Verwendung von technischen Dimerdiol/Trimertriol-Ge- misehen als ölkörper oder Überfettungsmittel für die Herstellung von kosmetischen und/oder pharmazeutischen Zubereitungen. 6. Use of technical dimer diol / trimer triol mixtures as an oil body or superfatting agent for the production of cosmetic and / or pharmaceutical preparations.
PCT/EP1996/000740 1995-03-02 1996-02-22 Cosmetic and/or pharmaceutical preparations Ceased WO1996026710A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19507203.0 1995-03-02
DE1995107203 DE19507203A1 (en) 1995-03-02 1995-03-02 Cosmetic and / or pharmaceutical preparations

Publications (1)

Publication Number Publication Date
WO1996026710A1 true WO1996026710A1 (en) 1996-09-06

Family

ID=7755396

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/000740 Ceased WO1996026710A1 (en) 1995-03-02 1996-02-22 Cosmetic and/or pharmaceutical preparations

Country Status (2)

Country Link
DE (1) DE19507203A1 (en)
WO (1) WO1996026710A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003051324A1 (en) * 2001-12-19 2003-06-26 Cognis Deutschland Gmbh & Co. Kg Cosmetic and/or pharmaceutical sunscreen preparations
FR2839308A1 (en) * 2002-04-24 2003-11-07 Croda Japan Kk DIOL DERIVATIVE AND COMPOSITION CONTAINING SAME
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
US7413753B2 (en) 2001-06-08 2008-08-19 Wyeth Calcium phosphate delivery vehicles for osteoinductive proteins

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2345406T3 (en) 2010-01-16 2017-02-28 Aachener Centrum Für Technologietransfer In Der Ophthalmologie E.V. Use of dimer diol in the production of bodily fluid substitutes
US8697756B2 (en) 2012-07-10 2014-04-15 Acto E.V. Dimer diol compositions as substitutes of body fluids

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1043507A (en) * 1964-02-25 1966-09-21 Marchon Products Ltd Cyclo-aliphatic diols and process for their preparation
US3947382A (en) * 1967-02-01 1976-03-30 Cincinnati Milacron, Inc. Mildness additive
US3981990A (en) * 1967-02-01 1976-09-21 Cincinnati Milacron, Inc. Skin protective compositions
GB1577926A (en) * 1976-11-03 1980-10-29 Johnson & Johnson Cloth or paper impregnated with skinprotective agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1043507A (en) * 1964-02-25 1966-09-21 Marchon Products Ltd Cyclo-aliphatic diols and process for their preparation
US3947382A (en) * 1967-02-01 1976-03-30 Cincinnati Milacron, Inc. Mildness additive
US3981990A (en) * 1967-02-01 1976-09-21 Cincinnati Milacron, Inc. Skin protective compositions
GB1577926A (en) * 1976-11-03 1980-10-29 Johnson & Johnson Cloth or paper impregnated with skinprotective agents

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
US7413753B2 (en) 2001-06-08 2008-08-19 Wyeth Calcium phosphate delivery vehicles for osteoinductive proteins
WO2003051324A1 (en) * 2001-12-19 2003-06-26 Cognis Deutschland Gmbh & Co. Kg Cosmetic and/or pharmaceutical sunscreen preparations
FR2839308A1 (en) * 2002-04-24 2003-11-07 Croda Japan Kk DIOL DERIVATIVE AND COMPOSITION CONTAINING SAME

Also Published As

Publication number Publication date
DE19507203A1 (en) 1996-09-05

Similar Documents

Publication Publication Date Title
EP1500427B1 (en) Emulsifier for low-viscosity w/o emulsions, based on partially crosslinked polyglycerin esters of polyhydroxystearic acid.
EP0554292B1 (en) Oil-in-water emulsions
EP0732912B1 (en) Cosmetic and/or pharmaceutical preparations with improved skin feel
WO1996027366A1 (en) Cosmetic and/or pharmaceutical preparations
DE19635553A1 (en) Emulsifier mixtures
EP1732877B1 (en) Sensory wax for cosmetic and/or pharmaceutical formulations
EP0143245B1 (en) O/w emulsifiers for cosmetic purposes
DE60216183T2 (en) TOPICAL COMPOSITIONS USING OUTER OIL PHASE AND METHOD FOR THE PRODUCTION THEREOF
DE69522859T2 (en) Cosmetic skin care products
DE10132842C1 (en) Transesterification of fats and/or oils by alcoholysis, e.g. for preparation of methyl esters useful as diesel fuel, with addition of alkanol fatty acid ester to give single-phase reaction mixture and high reaction velocity
WO1996026710A1 (en) Cosmetic and/or pharmaceutical preparations
EP4558119A2 (en) Method for producing a cosmetic water-in-oil emulsion from a glycerin-in-oil emulsion
DE4407015A1 (en) Cosmetic and / or pharmaceutical preparations
DE2023786C3 (en)
DE19740069A1 (en) Mixtures of long-chain phosphoric acid alkyl esters
EP1029586B1 (en) Emulsifiers
DE19604744A1 (en) Technical di- / triglyceride mixtures
DE10211140A1 (en) Stable dispersion concentrates
DE3723237C2 (en)
EP0830857B1 (en) Cosmetic compositions
DE1955764C3 (en)
DE1247332B (en) Process for the production of aqueous emulsions of oils, fats and waxes
WO2025036868A1 (en) Process for producing a cosmetic water-in-oil emulsion from a cold-emulsified glycerol-in-oil emulsion
WO1995035088A1 (en) Cosmetic and/or pharmaceutical o/w emulsions
WO2025036651A2 (en) Method for producing a new quickly emulsifiable cosmetic water-in-oil emulsion from a glycerin-in-oil emulsion

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase